Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 13/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2290670 | 1.00 | SLC6A9 (0.53) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL1144711 | 0.98 | SLC6A9 (0.51) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL16800540 | 0.98 | SLC6A9 (0.51) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL9182778 | 0.98 | SLC6A9 (0.51) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL16660371 | 0.92 | SLC6A9 (0.47) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL16660370 | 0.92 | SLC6A9 (0.47) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL2799303 | 0.90 | SLC6A9 (0.44) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL20978841 | 0.90 | SLC6A9 (0.44) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL24709148 | 0.88 | SLC6A9 (0.43) | SLC6A9SIGMAR1HSD17B10 | |
| SCHEMBL18872988 | 0.87 | SLC6A9 (0.44) | SLC6A9SIGMAR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150110715-A1 | Double-Labeled Probe for Molecular Imaging and Use Thereof | RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150110715-A1 | Double-Labeled Probe for Molecular Imaging and Use Thereof | CD47, ANXA5, CD44 | SLC6A9 373/4885SIGMAR1 1278/4885HSD17B10 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.